US Stock MarketDetailed Quotes

Relmada Therapeutics (RLMD)

Watchlist
  • 7.490
  • +0.040+0.54%
Close May 13 16:00 ET
  • 7.600
  • +0.110+1.47%
Pre 06:53 ET
785.63MMarket Cap-6.87P/E (TTM)

Relmada Therapeutics (RLMD) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
11.53%-45.79M
-65.87%-14.6M
59.64%-6.72M
51.73%-6.4M
-38.59%-18.07M
-0.19%-51.76M
14.15%-8.8M
-43.21%-16.66M
0.08%-13.26M
21.01%-13.04M
Net income from continuing operations
28.25%-57.39M
-6.49%-19.87M
53.55%-10.09M
44.47%-9.87M
19.56%-17.56M
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
Operating gains losses
121.13%79.21K
364.23%107.92K
155.09%81.44K
64.54%-47.2K
-18.48%-62.95K
-109.22%-374.93K
-101.22%-40.84K
-385.87%-147.84K
---133.11K
-107.97%-53.13K
Other non cash items
--905.23K
----
----
----
----
----
----
----
----
----
Change In working capital
-149.40%-3.95M
-57.51%1.23M
82.23%-438.07K
100.95%24.91K
-895.31%-4.77M
-151.41%-1.58M
-46.50%2.9M
-49.18%-2.47M
-1,288.33%-2.62M
165.65%599.76K
-Change in receivables
----
----
----
----
----
--0
--0
--0
--0
--0
-Change in prepaid assets
-127.77%-88.79K
-101.07%-7.5K
51.45%-493.12K
-40.39%121.78K
-32.97%290.05K
-88.75%319.75K
-57.77%698.34K
-261.89%-1.02M
153.11%204.31K
-54.24%432.72K
-Change in payables and accrued expense
-102.84%-3.86M
-43.71%1.24M
103.80%55.05K
96.57%-96.87K
-3,129.32%-5.06M
-594.48%-1.9M
-41.56%2.2M
36.41%-1.45M
-566.78%-2.82M
107.04%167.03K
Cash from discontinued investing activities
Operating cash flow
11.53%-45.79M
-65.87%-14.6M
59.64%-6.72M
51.73%-6.4M
-38.59%-18.07M
-0.19%-51.76M
14.15%-8.8M
-43.21%-16.66M
0.08%-13.26M
21.01%-13.04M
Investing cash flow
Cash flow from continuing investing activities
-193.36%-48.14M
-778.07%-76.93M
-58.17%6.75M
-52.34%6.68M
52.70%15.36M
2.20%51.56M
46.56%11.35M
318.19%16.14M
1,316.79%14.01M
-74.86%10.06M
Net investment purchase and sale
-193.36%-48.14M
-778.07%-76.93M
-58.17%6.75M
-52.34%6.68M
52.70%15.36M
2.20%51.56M
46.56%11.35M
318.19%16.14M
1,316.79%14.01M
-74.86%10.06M
Cash from discontinued investing activities
Investing cash flow
-193.36%-48.14M
-778.07%-76.93M
-58.17%6.75M
-52.34%6.68M
52.70%15.36M
2.20%51.56M
46.56%11.35M
318.19%16.14M
1,316.79%14.01M
-74.86%10.06M
Financing cash flow
Cash flow from continuing financing activities
232,034.78%93.56M
54,386.89%93.64M
0
-73.02K
0
59.03%-40.34K
-75.18%-172.49K
-89.6K
0
221.75K
Net common stock issuance
--93.64M
38,048.92%93.64M
----
----
----
--0
---246.75K
--0
----
----
Proceeds from stock option exercised by employees
--0
----
----
--0
--0
--246.75K
----
----
--0
--246.75K
Net other financing activities
74.56%-73.02K
--0
--0
----
----
-191.57%-287.09K
---172.49K
---89.6K
--0
---25K
Cash from discontinued financing activities
Financing cash flow
232,034.78%93.56M
54,386.89%93.64M
--0
---73.02K
--0
59.03%-40.34K
-75.18%-172.49K
---89.6K
--0
--221.75K
Net cash flow
Beginning cash position
-5.73%3.86M
-6.69%1.38M
-35.13%1.35M
-13.88%1.15M
-5.73%3.86M
-24.17%4.09M
-77.85%1.48M
-85.58%2.09M
-95.38%1.34M
-24.17%4.09M
Current changes in cash
-53.70%-360.49K
-11.01%2.11M
105.17%31.13K
-72.89%203.65K
1.79%-2.71M
82.02%-234.54K
191.03%2.37M
92.25%-602.47K
105.21%751.24K
-111.73%-2.76M
End cash Position
-9.35%3.5M
-9.35%3.5M
-6.69%1.38M
-35.13%1.35M
-13.88%1.15M
-5.73%3.86M
-5.73%3.86M
-77.85%1.48M
-85.58%2.09M
-95.38%1.34M
Free cash flow
11.53%-45.79M
-65.87%-14.6M
59.64%-6.72M
51.73%-6.4M
-38.59%-18.07M
-0.19%-51.76M
14.15%-8.8M
-43.21%-16.66M
0.08%-13.26M
21.01%-13.04M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 11.53%-45.79M-65.87%-14.6M59.64%-6.72M51.73%-6.4M-38.59%-18.07M-0.19%-51.76M14.15%-8.8M-43.21%-16.66M0.08%-13.26M21.01%-13.04M
Net income from continuing operations 28.25%-57.39M-6.49%-19.87M53.55%-10.09M44.47%-9.87M19.56%-17.56M19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M
Operating gains losses 121.13%79.21K364.23%107.92K155.09%81.44K64.54%-47.2K-18.48%-62.95K-109.22%-374.93K-101.22%-40.84K-385.87%-147.84K---133.11K-107.97%-53.13K
Other non cash items --905.23K------------------------------------
Change In working capital -149.40%-3.95M-57.51%1.23M82.23%-438.07K100.95%24.91K-895.31%-4.77M-151.41%-1.58M-46.50%2.9M-49.18%-2.47M-1,288.33%-2.62M165.65%599.76K
-Change in receivables ----------------------0--0--0--0--0
-Change in prepaid assets -127.77%-88.79K-101.07%-7.5K51.45%-493.12K-40.39%121.78K-32.97%290.05K-88.75%319.75K-57.77%698.34K-261.89%-1.02M153.11%204.31K-54.24%432.72K
-Change in payables and accrued expense -102.84%-3.86M-43.71%1.24M103.80%55.05K96.57%-96.87K-3,129.32%-5.06M-594.48%-1.9M-41.56%2.2M36.41%-1.45M-566.78%-2.82M107.04%167.03K
Cash from discontinued investing activities
Operating cash flow 11.53%-45.79M-65.87%-14.6M59.64%-6.72M51.73%-6.4M-38.59%-18.07M-0.19%-51.76M14.15%-8.8M-43.21%-16.66M0.08%-13.26M21.01%-13.04M
Investing cash flow
Cash flow from continuing investing activities -193.36%-48.14M-778.07%-76.93M-58.17%6.75M-52.34%6.68M52.70%15.36M2.20%51.56M46.56%11.35M318.19%16.14M1,316.79%14.01M-74.86%10.06M
Net investment purchase and sale -193.36%-48.14M-778.07%-76.93M-58.17%6.75M-52.34%6.68M52.70%15.36M2.20%51.56M46.56%11.35M318.19%16.14M1,316.79%14.01M-74.86%10.06M
Cash from discontinued investing activities
Investing cash flow -193.36%-48.14M-778.07%-76.93M-58.17%6.75M-52.34%6.68M52.70%15.36M2.20%51.56M46.56%11.35M318.19%16.14M1,316.79%14.01M-74.86%10.06M
Financing cash flow
Cash flow from continuing financing activities 232,034.78%93.56M54,386.89%93.64M0-73.02K059.03%-40.34K-75.18%-172.49K-89.6K0221.75K
Net common stock issuance --93.64M38,048.92%93.64M--------------0---246.75K--0--------
Proceeds from stock option exercised by employees --0----------0--0--246.75K----------0--246.75K
Net other financing activities 74.56%-73.02K--0--0---------191.57%-287.09K---172.49K---89.6K--0---25K
Cash from discontinued financing activities
Financing cash flow 232,034.78%93.56M54,386.89%93.64M--0---73.02K--059.03%-40.34K-75.18%-172.49K---89.6K--0--221.75K
Net cash flow
Beginning cash position -5.73%3.86M-6.69%1.38M-35.13%1.35M-13.88%1.15M-5.73%3.86M-24.17%4.09M-77.85%1.48M-85.58%2.09M-95.38%1.34M-24.17%4.09M
Current changes in cash -53.70%-360.49K-11.01%2.11M105.17%31.13K-72.89%203.65K1.79%-2.71M82.02%-234.54K191.03%2.37M92.25%-602.47K105.21%751.24K-111.73%-2.76M
End cash Position -9.35%3.5M-9.35%3.5M-6.69%1.38M-35.13%1.35M-13.88%1.15M-5.73%3.86M-5.73%3.86M-77.85%1.48M-85.58%2.09M-95.38%1.34M
Free cash flow 11.53%-45.79M-65.87%-14.6M59.64%-6.72M51.73%-6.4M-38.59%-18.07M-0.19%-51.76M14.15%-8.8M-43.21%-16.66M0.08%-13.26M21.01%-13.04M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More